Dr. Mohamed S. Morsy, MD

Dr. Morsy practices at First Physicians Group in North Venice, Florida.

Dr. Morsy's NPI, 1851670608, was assigned on August 11, 2011. Dr. Morsy graduated from Alexandria University Faculty of Medicine in 2008. Dr. Morsy holds Florida license ME147437.

Dr. Morsy's primary practice is First Physicians Group, at 200 Healthcare Way Unit 103 Unit 103, North Venice, FL 34275. The practice phone is (941) 261-0160.

Dr. Morsy's primary practice is First Physicians Group in North Venice, Florida. Dr. Morsy is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Dr. Morsy to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morsy practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Morsy's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Morsy is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Morsy's licenses on file in 3 states: Florida, Tennessee and Mississippi.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis, leg revascularization and pacemaker or defibrillator implantation among the conditions Dr. Morsy treats.

CMS data shows 7,384 Medicare services from Dr. Morsy across 40 procedure codes in 2024, for 2,300 Medicare patients. Medicare paid $482,469 for them.

CMS counts 2,300 Medicare patients who saw Dr. Morsy in 2024. The largest group is 75 to 84, with 975 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morsy's median patient age at 77, with 48% women.

In 2024, Dr. Morsy wrote 4,290 Medicare Part D claims for 731 patients. 84% of them were for generic drugs. CMS names the drug for 4,040 of them, across 34 drugs with 11 or more claims each, at $854,043 in total drug cost. In 2023, CMS named 2,316 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Morsy for performance year 2024, reported as part of a group. Dr. Morsy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of coronary angioplasty and stenting by Dr. Morsy, more than 74% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Morsy, published from 2015 to 2018. 2016 was the busiest year, with 4. The most frequent topics are Bone Transplantation, Coronary Angiography and Coronary Artery Disease. Dr. Morsy has published most often in Am J Med Sci. Dr. Morsy's most frequent co-authors are Rami Nadim Khouzam, MD, Steven L. Moran, MD and Assaf Kadar, MD.

CMS Open Payments shows 216 general payments to Dr. Morsy from 36 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 53% of the total. Medtronic, Inc. paid the most, $8,190.

Dr. Morsy graduated from Alexandria University Faculty of Medicine in 2008. Dr. Morsy is a member of ACC and SCAI.

Dr. Morsy is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.